ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q1Scopus Q2SCImago #10,115Diamond OAHybrid

BioMedicine-Taiwan

Identifier (ISSN):2211-8020(Print)/2211-8039(Online)
•
Publisher:China Medical University
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
3↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for BioMedicine-Taiwan

WoS Q1
12341.720232.120242.5202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q2
0.585
#10,115

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
38

38 papers with at least that number of citations each

WoS: ESCIQ1
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
33articles/year
98.59% Gold OA•94.12% Original Research

Aims & Scope

BioMedicine-Taiwan (ISSN: 2211-8020) is a peer-reviewed international scholarly journal in the field of MEDICINE, published by China Medical University in Taiwan. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q1 of Web of Science (ESCI), a Scopus SJR indicator of 0.585 (Q2), an H-index of 38.

Topics Covered (Recognized by AI)
Medicine97.4%Biology93.5%Internal medicine78.9%Genetics68.2%Chemistry58.8%Pathology55.2%Biochemistry54.9%Endocrinology40.3%Surgery36.7%Psychology32.5%Psychiatry26%Physics25.6%Immunology25.6%Gene23.4%Mathematics22.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

MEDICINE, GENERAL & INTERNAL

Q1
Rank73/336
IndexESCI
JCIESCI2026

MEDICINE, GENERAL & INTERNAL

Q2
Rank111/336
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year15
Total Citations0
2025
IF2.5
Articles / Year27
Total Citations34
2024
IF2.1
Articles / Year185
Total Citations163
2023
IF1.7
Articles / Year27
Total Citations224
2022
IF—
Articles / Year28
Total Citations251

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,115Scopus Q2Diamond OASCImago Profile
Scopus Coverage:2011-2025
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.585

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.00

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations228
3-Year Documents81
Citable Documents80

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2
Medicine (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区MEDICINE, GENERAL & INTERNAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

BioMedicine-Taiwan (ISSN: 2211-8020) is a peer-reviewed international scholarly journal in the field of MEDICINE, published by China Medical University in Taiwan. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q1 of Web of Science (ESCI), a Scopus SJR indicator of 0.585 (Q2), an H-index of 38.

The journal enforces rigorous peer evaluation with an annual output of approximately 33 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
China Medical University
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: aca34eac-5cec-4bfe-ab59-559503a92489
Database Updated: 2026-10-01